Schechter Investment Advisors LLC Has $1.82 Million Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Schechter Investment Advisors LLC raised its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 8.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 20,526 shares of the company’s stock after purchasing an additional 1,554 shares during the quarter. Schechter Investment Advisors LLC’s holdings in U.S. Physical Therapy were worth $1,821,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BNP Paribas Financial Markets grew its stake in U.S. Physical Therapy by 283.0% during the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after purchasing an additional 12,445 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of U.S. Physical Therapy by 57.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock worth $223,000 after buying an additional 956 shares during the period. State Street Corp grew its position in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after buying an additional 99,244 shares during the period. Stifel Financial Corp increased its stake in shares of U.S. Physical Therapy by 12.1% in the 3rd quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock valued at $4,838,000 after acquiring an additional 6,154 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its position in shares of U.S. Physical Therapy by 113.4% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 16,188 shares of the company’s stock valued at $1,370,000 after acquiring an additional 8,604 shares during the period.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Stock Down 2.1 %

USPH stock opened at $79.31 on Tuesday. The firm has a market capitalization of $1.20 billion, a PE ratio of 84.37, a P/E/G ratio of 3.54 and a beta of 1.48. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63. The stock’s 50 day moving average is $88.20 and its 200-day moving average is $87.65.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. Sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be issued a dividend of $0.45 per share. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. This represents a $1.80 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 97.83%.

Analyst Ratings Changes

A number of research firms have commented on USPH. JPMorgan Chase & Co. raised their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their price objective for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Finally, Barrington Research lowered their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $111.50.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.